trending news

5 most popular innovation stories in Houston this week

From Houston being named the among the top global cities for business to what events to attend at Dallas Startup Week, here's what news trended this week. Photo by PeopleImages

Editor's note: While Houston missed a major hurricane this week, preparations sidetracked the city a bit with virtual events — like Houston Climate Week — being canceled or postponed. However, major innovation news showed up in full force as usual.

3 Houston innovators to know this week

This week's Houston innovators to know include Nicolaus Radford of Houston Mechatronics Inc. and Sharita M. Humphry and Enrique Castro of BH Ventures. Photos courtesy

This week's roundup of innovators to know in Houston include three self-starting founders — a robotics expert who's job sounds more futuristic that realistic and a duo looking to bridge the gap between Black and Hispanic entrepreneurs while cultivating their business growth. Continuereading.

Here's what Dallas Startup Week events Houston entrepreneurs should attend

Dallas Startup Week has pivoted to online panels and chats. Here's which ones Houston innovators shouldn't miss. Getty Images

While a 4-hour trip up Interstate 45 might, in years prior, could have caused Houston entrepreneurs pause from attending the annual Dallas Startup Week, this year there's no excuse.

DSW is taking place online this year, and there are more than a couple virtual events Houston entrepreneurs need to attend. Here's which virtual events Houstonians should log on to. Continue reading.

Microsoft doubles down on partnership with the city of Houston by committing $1M to programs

Mayor Sylvester Turner announced that Microsoft has expanded its partnership with the city. Photo courtesy of Mayor's Office

Microsoft and the city of Houston have introduced a new program aimed at addressing technology skills development across Houston.

Accelerate: Houston is part of Microsoft's larger global skills initiative. Mayor Sylvester Turner announced the program at a press conference on Monday, August 24.

"More than two years ago, I announced our first transformative alliance with Microsoft — the first of its kind in the United States," says Mayor Sylvester Turner, according to a press release. "Today, I am pleased to say we are taking another leap toward strengthening Houston's global standing as a center for innovation and technology." Continue reading.

Texas A&M University approves $60.3M for military innovation project

A&M's Research Integration Center, which will house data and act as an innovation hub for innovators and military specialists, is expected to be completed next fall. Photo via tamu.edu

Texas A&M University is in the process of building a $200 million, multi-building facility just off its main campus in College Station and Bryan, Texas. As of this week, the project has fresh funds from the A&M Board of Regents to continue on with construction.

The board approved a $60.3 million projects at the George H.W. Bush Combat Development Complex, or BCDC, on the RELLIS Campus in Bryan, according to a press release from the university. According to a news release from the university, $22.5 million approved will go toward hypersonic and directed energy testing range called BAM — which stands for Ballistic, Aero-Optics, and Materials. At one kilometer long and two meters in diameter, BAM is expected to the largest enclosed hypersonic testing facility in the nation. Continue reading.

Houston ranked among world's top cities of the future for global business

Houston has been recognized as a city with high potential for global business. Photo by Tim Leviston/Getty Images

When it comes to global cities on track for continued global business success, Houston comes in third on a prestigious list recently released.

The new fDi Tier 2 Cities of the Future 2020/21 evaluated second tier cities — defined as non-capital cities with a population under eight million.

Last year, Houston ranked in the No. 5 position. This year, the city moved up in the ranking and held the No. 3 spot for human capital and lifestyle and the No. 7 spot for economic growth potential. Continue reading.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News